|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Osteoporosis | |||||
| Osteopenia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Bone Diseases, Metabolic | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Diseases | |||||
| Musculoskeletal Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Calcium carbonate | |||||
| Calcium phosphate | |||||
| Teriparatide | |||||
| Vitamin D | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antacids | |||||
| Bone Density Conservation Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | |||||
| Office of Dietary Supplements (ODS) | |||||